StockData
MDXHNasdaqServices-Medical Laboratories

MDxHealth SA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 3, 2026
$0.18−0.02 (-11.33%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2021
Ended Dec 31, 2021
Mar 3, 2022After market close–––

Press releases

Announcements MDxHealth filed with the SEC